Literature DB >> 31992537

The clinical characteristics of lower extremity lymphedema in 440 patients.

Steven M Dean1, Elizabeth Valenti2, Karen Hock3, Julie Leffler3, Amy Compston3, William T Abraham2.   

Abstract

BACKGROUND: Lower extremity lymphedema is frequently encountered in the vascular clinic. Established dogma purports that cancer is the most common cause of lower extremity lymphedema in Western countries, whereas chronic venous insufficiency (CVI) is often overlooked as a potential cause. Moreover, lymphedema is typically ascribed to a single cause, yet multiple causes can coexist.
METHODS: A 3-year retrospective analysis was conducted of demographic and clinical characteristics of 440 eligible patients with lower extremity lymphedema who presented for lymphatic physiotherapy to a university medical center's cancer-based physical therapy department.
RESULTS: The four most common causes of lower extremity lymphedema were CVI (phlebolymphedema; 41.8%), cancer-related lymphedema (33.9%), primary lymphedema (12.5%), and lipedema with secondary lymphedema (11.8%). The collective cohort was more likely to be female (71.1%; P < .0001), to be white (78.9%; P < .0001), to demonstrate bilateral distribution (74.5%; P < .0001), and to have involvement of the left leg (bilateral, 69.1% [P < .0001]; unilateral, 58.9% [P = .0588]). Morbid obesity was pervasive (mean weight and body mass index, 115.8 kg and 40.2 kg/m2, respectively) and significantly correlated with a higher International Society of Lymphology lymphedema stage (stage III mean weight and body mass index, 169.2 kg and 57.3 kg/m2, respectively, vs stage II, 107.8 kg and 37.5 kg/m2, respectively; P < .0001). Approximately one in three (35.7%) of the population sustained one or more episodes of cellulitis, but patients with stage III lymphedema had roughly twice the rate of soft tissue infection as patients with stage II, 61.7% vs 31.8%, respectively (P < .001). Multifactorial lymphedema was present in 25%. Approximately half of the patients with lipedema with secondary lymphedema (48.1%) or primary lymphedema (45.5%) had a superimposed cause of swelling that was usually CVI. Total knee arthroplasty was the most common cause of noncancer surgery-mediated worsening of pre-existing lymphedema.
CONCLUSIONS: In a large cohort of patients treated in a cancer-affiliated physical therapy department, CVI (phlebolymphedema), not cancer, was the predominant cause of lower extremity lymphedema. One in four patients had more than one cause of lymphedema. Notable clinical characteristics included a proclivity for female patients, bilateral distribution, left limb, cellulitis, and nearly universal morbid obesity.
Copyright © 2020 The Authors. Published by Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Chronic venous insufficiency; Lipedema; Lymphedema; Morbid obesity

Mesh:

Year:  2020        PMID: 31992537     DOI: 10.1016/j.jvsv.2019.11.014

Source DB:  PubMed          Journal:  J Vasc Surg Venous Lymphat Disord


  8 in total

Review 1.  Evaluation and Management of Patients with Leg Swelling: Therapeutic Options for Venous Disease and Lymphedema.

Authors:  Kimberly Scherer; Neil Khilnani
Journal:  Semin Intervent Radiol       Date:  2021-06-03       Impact factor: 1.780

2.  Filarial Lymphedema Patients Are Characterized by Exhausted CD4+ T Cells.

Authors:  Sacha Horn; Manuel Ritter; Kathrin Arndts; Dennis Borrero-Wolff; Anna Wiszniewsky; Linda Batsa Debrah; Alexander Y Debrah; Jubin Osei-Mensah; Mkunde Chachage; Achim Hoerauf; Inge Kroidl; Laura E Layland
Journal:  Front Cell Infect Microbiol       Date:  2022-01-06       Impact factor: 5.293

Review 3.  Healthcare Practitioners' Knowledge of Lymphedema.

Authors:  Hossein Yarmohammadi; Amirhossein Rooddehghan; Masood Soltanipur; Amirabbas Sarafraz; Seyed Fatah Mahdavi Anari
Journal:  Int J Vasc Med       Date:  2021-12-31

4.  The American Venous Forum, American Vein and Lymphatic Society and the Society for Vascular Medicine expert opinion consensus on lymphedema diagnosis and treatment.

Authors:  Fedor Lurie; Rafael D Malgor; Teresa Carman; Steven M Dean; Mark D Iafrati; Neil M Khilnani; Nicos Labropoulos; Thomas S Maldonado; Peter Mortimer; Thomas F O'Donnell; Joseph D Raffetto; Stanley G Rockson; Antonios P Gasparis
Journal:  Phlebology       Date:  2022-03-08       Impact factor: 1.701

5.  A non-randomized, open-label study of the safety and effectiveness of a novel non-pneumatic compression device (NPCD) for lower limb lymphedema.

Authors:  Stanley G Rockson; Pinar Karaca-Mandic; Michelle Nguyen; Kristin Shadduck; Phyllis Gingerich; Elizabeth Campione; Heather Hetrrick
Journal:  Sci Rep       Date:  2022-08-17       Impact factor: 4.996

6.  Tissue Dielectric Constant of the Lower Leg as an Index of Skin Water: Temporal Variations.

Authors:  Harvey N Mayrovitz
Journal:  Cureus       Date:  2022-07-01

7.  Circumferential and Depth Variations in Tissue Dielectric Constant Values as Indices of Lower Leg Localized Skin Water.

Authors:  Harvey N Mayrovitz
Journal:  Cureus       Date:  2022-08-02

8.  Standard of care for lipedema in the United States.

Authors:  Karen L Herbst; Linda Anne Kahn; Emily Iker; Chuck Ehrlich; Thomas Wright; Lindy McHutchison; Jaime Schwartz; Molly Sleigh; Paula Mc Donahue; Kathleen H Lisson; Tami Faris; Janis Miller; Erik Lontok; Michael S Schwartz; Steven M Dean; John R Bartholomew; Polly Armour; Margarita Correa-Perez; Nicholas Pennings; Edely L Wallace; Ethan Larson
Journal:  Phlebology       Date:  2021-05-28       Impact factor: 1.740

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.